Activist investor Politan Capital secured two board seats at medical technology company Masimo, ousting founder and CEO Joe Kiani and director Chris Chavez. According to an anonymous source familiar with the situation, Politan's nominees received approximately double the votes of Joe Kiani and Chris Chavez. The proxy battle involved fierce legal action. Masimo sued Politan over proxy statement errors, and Politan accused Masimo of manipulating votes. Masimo shares rose over 2% following the vote.
